The Use of Effect Sizes to Characterize the Nature of Cognitive Change in Psychopharmacological Studies: An Example With Scopolamine

Human Psychopharmacology - United Kingdom
doi 10.1002/hup.942
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Use of Pharmacogenetics in Bioequivalence Studies to Reduce Sample Size: An Example With Mirtazapine and CYP2D6

Pharmacogenomics Journal
Molecular MedicineGeneticsPharmacology
2012English

Psychopharmacological Studies in Mice

Yakugaku Zasshi
PharmacologyPharmaceutical Science
2016English

Use of Intensity Analysis to Characterize Land Use/Cover Change in the Biggest Island of Persian Gulf, Qeshm Island, Iran

Sustainability
DevelopmentManagementMonitoringEnvironmental ScienceRenewable EnergyEnergy EngineeringLawSustainabilityPlanningPolicyPower Technologythe EnvironmentGeography
2019English

Effect of Fermented Spirulina Maxima Extract on Cognitive-Enhancing Activities in Mice With Scopolamine-Induced Dementia

Evidence-based Complementary and Alternative Medicine
Alternative MedicineComplementary
2018English

Scopolamine but Not Lorazepam Modulates Face Repetition Priming a Psychopharmacological fMRI Study

Neuropsychopharmacology
PsychiatryMental HealthPharmacology
2002English

An Example to the Change of Earth Shape: Evidence of Tethys Sea in Di̇yarbakir

Middle East Journal of Science
2018English

The Nature of Cognitive Phenomenology

Philosophy Compass
Philosophy
2013English

Circadian Variation in Susceptibility to the Ambulation-Increasing Effect of Scopolamine in Mice.

The Japanese Journal of Pharmacology
1983English

The Use of Vibration Principles to Characterize the Mechanical Properties of Biomaterials

2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy